Hypertension – Medxy AI

Predicting 10-Year Risk of Hypertension in Women Post-Pregnancy: Insights from a Population-Based Cohort Study

By MedXY 10/22/2026

Incorporating pregnancy-related factors, especially hypertensive disorders of pregnancy, significantly improves the prediction of 10-year incident hypertension risk in women after their first childbirth, potentially guiding targeted cardiovascular prevention.

Cardiology news

Unveiling the Role of Angiotensin II-Driven TGF-β1 in Enhancing Platelet PAR4 Expression and Thrombotic Risk in Hypertension

By MedXY 09/21/2026

This study reveals that angiotensin II via TGF-β1 upregulates platelet PAR4, promoting hyperactivation and thrombosis in hypertension, with valsartan attenuating this pathway and thrombotic risk.

Cardiology Gastroenterology news

Intestinal Serotonergic Vagal Signaling: A Novel Link Between Gut Microbiota and Hypertension Management

By MedXY 09/17/2026

Recent research identifies intestinal serotonin 5-HT3a receptor signaling via vagal neurons as a key mediator of microbiota-induced hypertension, offering new insights into resistant hypertension and potential therapeutic targets.

Cardiology news Superintelligence

Impact of an AI-Powered Gamified Mobile Health Application on Blood Pressure Control in a Matched Patient Cohort

By MedXY 09/16/2026

Study found that use of an AI-driven gamified mobile app integrating home blood pressure monitoring significantly improved blood pressure control compared to usual care in hypertensive patients.

news OB/GYN & Women's Health Public Health

Sustained Reduction of Severe Maternal Morbidity and Racial Disparities Through a Statewide Perinatal Quality Collaborative

By MedXY 09/08/2026

A Louisiana statewide perinatal quality collaborative significantly reduced severe maternal morbidity related to hemorrhage and hypertension, sustained improvements across initiatives, and narrowed racial disparities, demonstrating durable health system impact.

Cardiology news Public Health

Sustained Cardiovascular Benefits of Intensive Blood Pressure Management Led by Nonphysician Providers: 7-Year Follow-Up of the CRHCP Trial

By MedXY 08/30/2026

Long-term intensive BP control led by trained nonphysician community providers significantly lowers cardiovascular risk over 7 years, with benefits persisting 3 years post-intervention in rural China.

Cardiology news Public Health

Impact of a Community- and Family-Based Intervention on Blood Pressure Reduction in Rural China: Insights from a Cluster-Randomized Trial

By MedXY 08/28/2026

This cluster-randomized trial in rural China demonstrates that a coordinated community- and family-based intervention effectively lowers systolic blood pressure at the population level, highlighting the importance of sustained community engagement for hypertension control.

Cardiology Clinical Updates news

Evaluating the Clinical and Health Outcomes of Financial Incentives in Hypertension Management: A Comprehensive Review

By MedXY 08/11/2026

This review synthesizes evidence on physician-focused financial incentives for hypertension control, highlighting nuanced impacts on clinical decisions, documented blood pressure control, and cardiovascular outcomes, with a focus on both overall and borderline hypertensive populations.

Clinical Updates news Otorhinolaryngology

Hypoglossal Nerve Stimulation and Cardiovascular Disease Risk in Obstructive Sleep Apnea: A Comprehensive Review

By MedXY 07/24/2026

This review synthesizes current evidence on the impact of hypoglossal nerve stimulation (HGNS) on cardiovascular disease incidence in obstructive sleep apnea patients, highlighting potential long-term cardiovascular benefits and mechanistic insights.

Cardiology news Public Health

Unraveling Cardiovascular Health Improvements Post-Antihypertensive Intervention: Insights from the CRHCP Trial

By MedXY 07/12/2026

This analysis of the China Rural Hypertension Control Project reveals that intensive blood pressure management chiefly drives cardiovascular risk reduction, with modest contributions from behavioral and metabolic changes, highlighting domain-specific intervention effects.

Anesthesiology Critical Care news

Optimizing Intraoperative Blood Pressure in Hypertensive High-Risk Patients: Insights from the HISTAP Trial

By MedXY 07/09/2026

In hypertensive high-risk patients undergoing major abdominal surgery, targeting an intraoperative mean arterial pressure ≥80 mmHg reduces postoperative organ dysfunction and acute kidney injury compared to the standard target of ≥65 mmHg.

Diabetes & Endocrinology news Ophthalmology

Blood Pressure Assessment in Ophthalmology Clinics for Patients With Diabetes: A Case Series Analysis

By MedXY 07/09/2026

This case series reveals a high prevalence of uncontrolled hypertension among diabetic patients visiting ophthalmology clinics and highlights the importance of in-clinic blood pressure screening to identify and manage cardiovascular risk.

Diabetes & Endocrinology news

Expanding Technology-Enabled, Nurse-Delivered Chronic Disease Care: A Pragmatic, Randomized, Effectiveness-Implementation Trial

By MedXY 06/30/2026

This study evaluates comprehensive nurse-led telehealth for uncontrolled type 2 diabetes and hypertension in a fee-for-service setting, finding limited improvement in HbA1c but identifying key barriers to implementation.

Cardiology news Public Health

Impact of Fructose-Containing Beverages and Foods from Childhood to Adulthood on Hypertension Risk: Evidence from the GUTS Cohort

By MedXY 06/24/2026

This prospective cohort study investigates how fructose-containing beverages and foods, including sugar-sweetened beverages, fruit juices, and whole fruits, consumed from childhood through adulthood influence hypertension risk, highlighting differential effects based on source and offering insights for public health guidance.

Cardiology Internal Medicine news

Galectin-3 Regulates Smooth Muscle Contraction and Blood Pressure by Modulating CaV1.2 Channel Function

By MedXY 06/17/2026

Researchers found that Galectin-3 boosts CaV1.2 calcium channel activity in blood vessel muscle, increasing contraction and blood pressure. Blocking this interaction lowered blood pressure in animal models, suggesting a new target for hypertension treatment.

Cardiology Neurology news

Hypertension-Related High-Risk Features May Identify Which Patients With Cryptogenic Stroke Benefit From Apixaban Instead of Aspirin

By MedXY 06/10/2026

An exploratory ARCADIA analysis suggests that patients with cryptogenic stroke and atrial cardiopathy without severe hypertension-related features may derive greater benefit from apixaban than aspirin, whereas those with high-risk hypertensive features may not.

Cardiology news Public Health

Low-Level Airborne Particulate Matter and Risk of Hypertension Hospitalization in Older U.S. Adults

By MedXY 06/10/2026

A large U.S. study found that even PM2.5 levels below current federal standards were linked to higher hypertension hospitalization risk in older adults, especially among women and some regional and socioeconomic groups.

Cardiology news Public Health

Low-Level Airborne Particulate Matter and Risk of Hypertension Hospitalization in Older U.S. Adults

By MedXY 06/10/2026

Among more than 26 million older U.S. adults, even PM2.5 levels below current standards were linked to higher hypertension hospitalization risk, suggesting no clearly safe low-exposure threshold.

Cardiology news Public Health

Telehealth Navigation and Remote Blood Pressure Monitoring Were Linked to Better Hypertension Control in Black Patients at Federally Qualified Health Centers

By MedXY 06/09/2026

An observational study in a Massachusetts FQHC network found that a telehealth navigator program with remote monitoring was associated with a substantial improvement in blood pressure control among Black adults with hypertension.

Diabetes & Endocrinology Neurology news

Genetic Evidence Strengthens High BMI as a Causal Driver of Vascular Dementia, With Blood Pressure as a Partial Mediator

By MedXY 06/03/2026

A 2026 Mendelian randomization study supports high BMI as a causal risk factor for vascular-related dementia, with part of the effect mediated through elevated systolic and diastolic blood pressure.